For the past 20+ years, Innovaderm has been offering clinical research services of superior quality, serving its partners in their journey to discover new dermatologic therapies and ultimately, helping patients gain access to new and safe treatments.
Have a significant impact on patients' health and quality of life by supporting the advancement of medical knowledge and the development of new therapies.
To be the leading global CRO in dermatology through innovative research and development.
We promote cross-functional teamwork. We understand where others are coming from, we are aware of the impact of our actions and act appropriately. We create a safe space that promotes accountability and collaboration.
Seek out innovation
We are creative and solution-oriented. We actively look for solutions and implement them to add value in everything we do.
We work relentlessly for quality and client satisfaction on our 3 front lines: sponsors, research sites and research subjects. Whether or not we interact with the immediate front-line, we recognize that the sum of our contributions, no matter how big or small, is essential to our shared success.
Dare to take action
We are empowered to take action. We strive to deliver the best solutions in the shortest timeframe. We manage our responsibilities and tasks through personal accountability.
In 2000, Innovaderm began its activities as a clinical research site specialized in dermatology. It quickly built a strong reputation based on quality of its clinical research, its successful enrollment strategies and the care offered to its study participants.
In 2004, Innovaderm initiated strategic partnerships with research centers in the United States and Canada to offer its sponsors access to other high-quality dermatology sites. Since then, Innovaderm has created an extensive database of collaborating sites in North America.
In 2007, Innovaderm expanded its activities to include Clinical Research Organization (CRO) services for studies in dermatology. Our company offers a unique combination of a full-service CRO with advanced scientific capabilities and an expert clinical site network.
Innovaderm is internationally renowned for its numerous research studies on psoriasis, acne and atopic dermatitis, as well as for studies involving biologics and photodynamic therapy (PDT). Over 64% of our team has a background in life sciences and over 55% has a postgraduate degree (Master’s, PhD or MD).
Our Executive Team
Robert Bissonnette, MD, FRCPC
Founder and CEO
Dr. Robert Bissonnette is the chief executive officer and medical director at Innovaderm, the company he established in 2000. For more than 20 years, Dr. Bissonnette has dedicated his efforts towards the advancement of research in dermatology. Dr. Bissonnette has conducted nearly 200 studies ranging from proof-of-concept to phase III. As a Key Opinion Leader, he has extensive knowledge of clinical dermatology, clinical research, and the dermatology market, and is a great asset to our clients. Dr. Bissonnette has published more than 140 articles and book chapters, and delivers lectures on various aspects of dermatology at national and international conferences. After receiving his medical degree from the University of Montreal, he completed his residency training in dermatology followed by his clinical research training at McGill University and the University of British Columbia. Dr. Bissonnette is a board-certified dermatologist and served as an associate professor of dermatology at the University of Montreal until 2004. He is regularly invited to advisory board meetings to share his expert opinion on clinical product development. Dr. Bissonnette is internationally renowned for his clinical expertise in atopic dermatitis and psoriasis.
Jasmina Jankicevic, MD, MSc, CCRP
Chief Medical Officer
Dr. Jasmina Jankicevic is a key opinion leader in the field of dermatology drug/device development and medical affairs. Since 2004, she has headed global clinical development and medical strategy in dermatology and medical aesthetics for CROs, pharmaceutical, biotechnology and cosmetic companies including Premier Research, Allergan, Leo Pharma, and Murad. Over the years, Dr. Jankicevic’s work has led to the implementation of 300+ clinical study protocols for more than 20 different medical and cosmetic dermatology indications. As a leader and mentor serving on global cross-functional teams, she has shared her expertise on the fundamentals of successful regulatory submissions, product launches, and prosperous lifecycle management, while inspiring innovation in therapeutic solutions for both common and rare skin diseases, and aesthetic conditions. Dr. Jankicevic holds a Doctor of Medicine, a Master of Medical Science, and boardcertification in dermatology and venereology from the University of Belgrade in Serbia. Additionally, she is a renowned keynote speaker, a trained journalist, and the author of 150+ articles in peer-reviewed and trade journals.
Chief Business Officer
Jason Shuris served as Innovaderm’s Vice President of Business Development from 2018-2021. Following a short leave, he returned to Innovaderm in August 2022 as Chief Business Officer. Jason oversees the sales and marketing activities at the organization. In addition, he plays a key role in strategy planning and execution. Jason began his career in finance, occupying different roles in the accounting departments of privately held hospitals in Boston. He then worked in the life sciences sector as the controller at several biotechnology companies before entering the CRO industry in 2011. To date, he has held various leadership positions at ophthalmology and dermatology-focused CROs. Jason holds a Master of Science in Accounting from Bentley University (MA).
Chief Financial Officer
Stéphane Lussier joined Innovaderm in 2020 and is currently the Chief Financial Officer. His responsibilities include the management of external and internal accounting, financial reporting and planning and tax analysis. Stéphane has 20+ years of leadership experience in finance and operations in medium-sized and large enterprises. His previous roles include, senior director of finance for the Canadian business division of a US-based publicly traded company in the aeronautic industry. Stephane holds a bachelor’s degree in Business Administration from the Université du Québec à Montréal. He is also a Certified Public Accountant (CPA-CMA).
Anne Marie Gaulin
Executive VP, Europe Expansion
Anne Marie Gaulin is responsible for the creative vision and strategic plan of action for Innovaderm’s European Expansion initiative. Based in Europe, she will develop the region’s clinical trial activities and expertise. Anne Marie joined Innovaderm in 2009 as the director of business development. A strategic thinker, she greatly contributed to the success and growth of the company by managing sales, marketing, recruitment, operations and commercial development. Anne Marie’s sound knowledge of clinical trials in dermatology and 25+ years’ experience in the pharmaceutical industry fostered strong relationships with our clients. Prior to joining Innovaderm, she worked in business development at Cirion Biopharma, served as an operations manager at Alcan Packaging, and occupied different roles in sales and marketing at Rhône-Poulenc Rorer (now Sanofi) and Sandoz Consumer Health, a division of Novartis.
VP, Human Resources
Yvon Leduc serves as the Vice President of Human Resources at Innovaderm. His responsibilities include developing strategies, establishing programs and setting goals for the department while fostering a diverse workplace that allows employees to flourish. Yvon has 25+ years of leadership experience in human resources management. Prior to joining Innovaderm, he was a Senior Director of Human Resources at a global pharmaceutical company. Yvon holds a bachelor’s degree in Industrial Relations from the University of Montreal. He also holds the designation of Chartered Professional in Human Resources (CPHR) from Quebec.
VP, Process Improvement
Guillaume Gigon joined Innovaderm in 2018 and is currently the Vice President of Process Improvement. Throughout his career, he has held different positions including managing director at a large CRO. Guillaume has 15+ years’ experience in the clinical trial and biomedical industries, including project management and validation. He holds a Master of Science in Biochemistry, a DESS in Information Technology and multiple certifications including Certified CSTB Tester, LSS Green Belt and Portfolio Management.
VP, Project Management
Diane Leclerc joined Innovaderm in 2021 in the role of Senior Director, Project Delivery and was promoted to Vice President, Project Management in October 2022. She currently leads the Project Management department comprised of Project Delivery, Patient Recruitment, Vendor Management, Project Start-up and Operational Support, Operational Strategy and Project Management Learnings and Development. Her group includes employees based in North America, Europe, and Asia. Diane is a versatile, seasoned and dynamic executive leader experienced in the management of large portfolios with strategic partners in the pharmaceutical and biotechnology industries. She is well-versed in the development phasess of investigational products and medical devices in several therapeutic areas including dermatology. Diane holds a bachelor’s degree in Nursing Sciences from Université Laval and is certified as both a clinical research and project management professional by the Society of Clinical Research Associates (SOCRA) and the Project Management Institute (PMI).
Pina D’Angelo holds a master’s degree in Mathematics and Statistics from McGill University. She has worked in the pharmaceutical industry for over 25 years, both on the generic as well as on the innovator side. Pina has extensive experience in many therapeutic areas in clinical trials ranging from Phase 1 to 4 studies to PK/PD and bioequivalence studies. She has also served as a lecturer of statistics for at various colleges and universities in Montreal and Toronto.
Sr. Director, Quality and Compliance
Mélanie Pomerleau joined Innovaderm in 2018 as Director, Quality Assurance. For the past four years, she has held the position of Senior Director, Quality and Compliance. Mélanie has over 25 years of experience in the pharmaceutical industry, with a focus on clinical research. She has served as a quality assurance manager in large CROs in both Canada and the United States (Phase I and II). Additionally, she was the Head of Clinical Quality for a small-sized pharmaceutical company specialized in women’s health where she was actively involved in phase III studies and post-approval monitoring.
Our team is fully invested in the development of your projects, striving to help you achieve success in your mission of improving patients’ lives. Our teams are devoted to applying custom solutions to the complex and ever-changing landscape of clinical research and development.
To overcome these challenges, our team, with their life-sciences background, is trained in dermatology and understands the intricacies of your clinical program. In addition, our Quality Assurance unit is dedicated to supporting your project throughout each step of its execution, endeavoring to meet high-standard quality controls.
Our continuous and rapid growth positions us to tackle the most difficult aspects of your dermatology clinical trials. We are always aiming to exceed your expectations, contact us to learn more about our capabilities.
We are located in Montreal, one of the largest and most multicultural cities in North America. Montreal is internationally renowned for its world-class education and for its large pool of diverse talent. Many of the world’s top research and technology institutions are located in Montreal, making it a remarkable science and innovation hub.
With its significant number of teaching hospitals, phase 1 units, laboratories and access to a large pool of research volunteers coming from diverse ethnic backgrounds, Montreal is a significant contributor to clinical research.
We have modern, state-of-the-art facilities that are conveniently located in downtown Montreal, 30 minutes away from the Montreal-Trudeau International Airport.